Evidence map›Paper›PMID 41343278›Full record

ArticleCell reports2025

Cadherin-1-mediated communication at the leader-follower boundary controls mouse breast tumor organoid collective migration.

Vasilios A Morikis, Diego Barra Avila, Alessandra DiMauro, Yanyang Cao, Priscilla Y Hwang, Amit Pathak, Gregory D Longmore

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vasilios A MorikisICCE Institute, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Medicine (Oncology), Washington University in St. Louis, St. Louis, MO 63110, USA.
Diego Barra AvilaDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63110, USA.
Alessandra DiMauroICCE Institute, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Medicine (Oncology), Washington University in St. Louis, St. Louis, MO 63110, USA.
Yanyang CaoICCE Institute, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Medicine (Oncology), Washington University in St. Louis, St. Louis, MO 63110, USA.
Priscilla Y HwangCollege of Engineering, Virginia Commonwealth University, Richmond, VA, USA.
Amit PathakDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Mechanical Engineering and Materials Science, Washington University in St. Louis, St. Louis, MO 63110, USA.
Gregory D LongmoreICCE Institute, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Medicine (Oncology), Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University in St. Louis, St Louis, MO 63110, USA. Electronic address: glongmore@wustl.edu.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
MOLECULAR ONCOLOGY TRAINING GRANTT32CA113275 · NCI · WASHINGTON UNIVERSITY · PI Matthew J Walter · 2006 to 2026
$5.7M
Leader cell development and function in Breast Tumor Collective MigrationR01CA254060 · NCI · WASHINGTON UNIVERSITY · PI Gregory D. Longmore, Amit Pathak · 2022 to 2026
$2.6M
Epithelial Cell Mechanobiology in Mechanically Heterogeneous MicroenvironmentsR35GM128764 · NIGMS · WASHINGTON UNIVERSITY · PI PATHAK, AMIT · 2018 to 2022
$2.2M
Tumor stromal effects of DDR2 in metastasis regulationR01CA223758 · NCI · WASHINGTON UNIVERSITY · PI LONGMORE, GREGORY D. · 2018 to 2022
$1.9M
The role of DDR2 in the breast cancer microenvironmentF30CA200386 · NCI · WASHINGTON UNIVERSITY · PI BAYER, SAMANTHA VAN HOVE · 2016 to 2018
$109k
Chemo-Mechanical Feedback between CAFs, Leader Cells, and the Extracellular Microenvironment Regulates Leader Cell Regulated Collective Cell MigrationF32CA275212 · NCI · WASHINGTON UNIVERSITY · PI MORIKIS, VASILIOS ARIS · 2022 to 2022
$70k
NCI NIH HHS F30 CA200386NCI NIH HHS F32 CA275212NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA223758NCI NIH HHS R01 CA254060NCI NIH HHS T32 CA113275NIGMS NIH HHS R35 GM128764
6 · The paper itself

Abstract

In breast tumor collective migration, a minority of tumor cells lead the group while most tumor cells follow. Leader and follower tumor cells are molecularly and functionally heterogeneous, yet communications between these cells, particularly at the leader/follower interface, promote directional movement while sustaining cohesiveness. Through 3D computational simulations and live video 3D imaging of primary mouse breast tumor organoids in a microfluidic device, we investigated the roles of type I cadherins during collective migration. Cdh1 in follower cells and Cdh3 in leader cells are both critical for collective migration. Cdh1 function at the leader/follower boundary maintains cohesivity. Cdh3 in leader cells is important for leader cell polarization. Cancer-associated fibroblasts (CAFs) co-localize with leader cells and require leader cells to enhance collective migration. Cdh11, but not Cdh2, in CAFs is important for collective migration. These findings highlight how differential cadherin-mediated communication between cells maintains organization during collective migration.

Indexed as

Breast NeoplasmsCadherinsCdh1 ProteinsCell CommunicationCell MovementMammary Neoplasms, AnimalOrganoidsAnimalsFemaleHumansMiceCadherinsCdh1 protein, mouseCdh1 Proteinscadherinscollective cell migrationcomputational modelingCP: cancerCP: cell biologymicrofluidic devicestumor organoids

Identifiers

PMID41343278
PMCPMC12826098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.